Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Domain Therapeutics describes new adenosine A2A and A3 receptor antagonists

Sep. 17, 2010

DHEAS levels in plasma identified as putative biomarker for fibromyalgia

Sep. 17, 2010

Almirall describes pre-candidate agents for multiple sclerosis

Sep. 17, 2010

Enoxaparin yields superior net clinical benefit to UFH in subjects undergoing PCI for STEMI

Sep. 17, 2010

Lundbeck and Argenta disclose promising preclinical data on MCH1 receptor antagonists

Sep. 17, 2010

RAAM-DHF trial finds eplerenone may benefit patients with diastolic heart failure

Sep. 17, 2010

PAF-R is potential target to treat psoriasis

Sep. 17, 2010

GSK presents new prostanoid DP1 receptor antagonists

Sep. 16, 2010

New fatty-acid amide hydrolase 1 inhibitor JNJ-40355003 has preclinical analgesic effects

Sep. 16, 2010

BT-061 improves psoriasis in double-blind trial

Sep. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...